✦ LIBER ✦

P31 Biliary pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in surgery patients

✍ Scribed by Uegami, S.; Ohge, H.; Ikawa, K.; Shigemoto, N.; Nakashima, A.; Ikeda, K.; Morikawa, N.; Sueda, T.

Book ID: 123389115
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 62 KB
Volume: 42
Category: Article
ISSN: 0924-8579
DOI: 10.1016/S0924-8579(13)70276-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Pharmacokinetics of Meropenem a

Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic Target Attainment

✍ Ikawa, K.; Nakashima, A.; Morikawa, N.; Ikeda, K.; Murakami, Y.; Ohge, H.; Deren 📂 Article 📅 2011 🏛 American Society for Microbiology 🌐 English ⚖ 630 KB

Pharmacokinetics and tissue distribution

Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery

✍ A.R. Gascón; E. Campo; E. Olea; R.M. Hernández; B. Calvo; J. Errasti; J.L. Pedra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

The plasma levels and tissue penetration of pefloxacin were studied after prophylactic administration to patients undergoing elective biliary surgery. Pefloxacin was administered as a single dose of 800 mg given intravenously as an infusion 1 h before surgery. Over a period of two years, cultures of

Pharmacokinetics and Tissue Distribution

Pharmacokinetics and Tissue Distribution of Intravenous Ofloxacin for Antibiotic Prophylaxis in Biliary Surgery

✍ A. R. Gascón, E. Campo, R. M. Hernández, B. Calvo, J. Errasti, Dr J. L. Pedraz 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 256 KB

Peritoneal penetration and pharmacodynam

Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients

✍ Kazuro Ikawa; Norifumi Morikawa; Shusaku Matsuda; Kayo Ikeda; Hiroki Ohge; Yoshi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Optimisation of imipenem regimens in pat

Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data

✍ Kenichi Yoshizawa; Kazuro Ikawa; Kayo Ikeda; Hiromi Kumon; Hiroki Ohge; Norifumi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 401 KB

Clinical pharmacokinetics of meropenem i

Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: Dosing considerations

✍ Kondo, Naru; Ikawa, Kazuro; Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 405 KB